期刊文献+

钙调神经磷酸酶在cTnI基因Asp128Tyr突变致心肌肥大中的作用 被引量:3

Role of calcineurin in cTnI Asp128Tyr mutation-induced myocardial hypertrophy
下载PDF
导出
摘要 目的:探讨钙调神经磷酸酶(CaN)在心肌钙蛋白I(cTnI)基因第128位天冬氨酸→酪氨酸(Asp128Tyr)突变致心肌肥大中的作用。方法:乳鼠心肌细胞,以心钠素(ANF)、脑钠肽(BNP)mRNA表达作为心肌肥大指标,观察含cTnI Asp128Tyr突变基因的腺病毒转染对心肌细胞的作用,并观察CaN抑制剂环孢菌素A(CsA)或FK506对突变基因转染的影响。Real-time PCR检测ANF、BNP和CaN mRNA表达变化,同时行CaN活性测定。结果:转染含cTnI Asp128Tyr突变基因腺病毒的心肌细胞增大,胞内ANF和BNP的mRNA表达较空白对照组、不含任何目的基因的阴性对照腺病毒转染组和转染含野生型cTnI基因的腺病毒组增高(P<0.05)。与含野生型cTnI基因的腺病毒组相比,转染含cTnI Asp128Tyr突变基因的腺病毒组在ANF和BNP mRNA表达升高的同时存在CaN活性升高和CaN mRNA表达上调(P<0.05)。转染含cTnI Asp128Tyr突变基因的腺病毒并用CsA或FK506干预后,心肌细胞缩小,胞内ANF和BNP mRNA表达量较单纯转染含cTnI Asp128Tyr突变基因的腺病毒组降低(P<0.05),同时心肌细胞内CaN活性显著下降(P<0.05),CaN mRNA表达下调(P<0.05)。结论:cTnI Asp128Tyr突变可引起心肌细胞肥大;CaN信号通路参与了cTnI Asp128Tyr突变致心肌肥大过程的调控。 AIM:To investigate the role of calcineurin (CaN) signaling pathways in myocardial hypertrophy induced by cTnI Asp128Tyr mutation. METHODS: The adenovirus conlaining cTnI Asp128Tyr mutation was transfeeted into the cultured neonatal rat cardiomyocytes.Cardliac hypertrophy was evaluated by determining the mRNA expression of atrial natriure-tic factor(ANF) and brain natriuretic peptide(BNP)in the transfected ceils, The effects of CaN inhibitors eyclosporine A(CsA) and FK506 on cardiac hypertroply were also observed.The mRNA expres-sion of ANF ,BNP and CaN was measured by real-time quantitative PCR.The aetivity of CaN eas detected.RESULTS:Compared with blank control group,negative control virus group or virus conlaining wildtype cTnI gene group,the mRNA expression of ANF and BNP in mutation group(transfected with the adenovirus containing cTnI Asp 128Tyr mutation)significantly increased,and decreased after treatment with CsA or FK506.The mRNA exression and activity of CaN inerrased in the mutation group compared with blank control group,negative eontrol virus group or virus containing wildtype cTnI gene.At the same time,the mRNA expression and the activity of CaN decreased after treatment with CsA or FK506.CONCLUSION:Calcineurin signaling pathway is involved in the cardiac hypertophy induced by cTnI Asp128Tyr mutation.
出处 《中国病理生理杂志》 CAS CSCD 北大核心 2014年第5期923-927,共5页 Chinese Journal of Pathophysiology
基金 国家自然科学基金资助项目(No.30971224 No.30971223) 江苏省六大人才高峰资助项目(No.WS-054) 江苏省"333工程"科研资助项目(No.BRA2012213)
关键词 心肌钙蛋白I 基因突变 钙调神经磷酸酶 心肌肥大 Cardiac troponin 1 Gene mutation Calcineurin Myocardial hypertrophy
  • 相关文献

参考文献15

  • 1Ho CY. Genetic considerations in hypertrophic cardiomyopathy[J]. Prog Cardiovasc Dis, 2012, 54(6) :456-460.
  • 2盛红专,单其俊,吴翔,曹克将.心肌肌钙蛋白Ⅰ基因Asp127Tyr突变与肥厚型心肌病[J].中华心血管病杂志,2008,36(12):1063-1065. 被引量:3
  • 3Lind JM, Chiu C, Semsarian C. Genetic basis of hypertrophic cardiomyopathy [J]. Expert Rev Cardiovasc Ther, 2006, 4 (6) :927-934.
  • 4Molkentin JD. Parsing good versus bad signaling pathways in the heart: role of calcineurin-nuclear factor of activated T-cells[J]. Circ Res, 2013, 113(1): 16-19.
  • 5Rajapurohitam V, Izaddoustdar F, Martinez-Abundis E, et al. Leptin-indueed cardiomyocyte hypertrophy reveals both calcium-dependent and calcium-independent/RhoA-dependent ealcineurin activation and NF AT nuclear translocation [J]. Cell Signal, 2012, 24 (12) : 2283 -2290.
  • 6Zhao Y, Wang C, Wu J, et al. Choline protects against cardiac hypertrophy induced by increased after-load [J]. Int J Biol Sci, 2013, 9(3) :295-302.
  • 7姜庆军,徐耕,朱有法.伊贝沙坦和培垛普利对大鼠压力负荷性心肌肥厚的影响[J].中国病理生理杂志,2004,20(5):827-831. 被引量:4
  • 8Chen SN, Czernuszewicz G, Tan Y, et al. Human molecular genetic and functional studies identify TRIM63, encoding muscle RING finger protein I , as a novel gene for human hypertrophic cardiomyopathy [J]. Circ Res, 2012, 111(7) :907-919.
  • 9Fatkin D, McConnell BK, Mudd JO, et al. An abnormal Ca2 + response in mutant sarcomere protein-mediated familial hypertrophic cardiomyopathy [J]. J Clin Invest, 2000, 106(11) :1351-1359.
  • 10Ruggiero A, Chen SN, Lombardi R, et al. Pathogenesis of hypertrophic cardiomyopathy caused by myozenin 2 mutations is independent of calcineurin activity [J]. Cardiovasc Res, 2013, 97 (1) :44-54.

二级参考文献21

  • 1Maron B J, McKenna WJ, Danielson GK, et al. American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines. Eur Heart J, 2003, 24 : 1965-1991.
  • 2Seidman JG, Seidman C. The genetic basis for cardiomyopathy: from mutation identification to mechanistic paradigms. Cell, 2001, 104:557-567.
  • 3Alcalai R, Seidman JG, Seidman CE. Genetic basis of hypertrophic cardiomyopathy: from bench to the clinics. J Cardiovasc Electrophysio1,2008,19 : 104-110.
  • 4Gomes AV, Harada K, Potter JD. A mutation in the N-terminus of troponin I that is associated with hypertrophic cardiomyopathy affects the Ca (2 + )-sensitivity, phosphorylation kinetics and proteolytic susceptibility of troponin. J Mol Cell Cardiol, 2005, 39:754-765.
  • 5Kruger M, Zittrich S, Redwood C, et al. Effects of the mutation R145G in human cardiac troponin I on the kinetics of the contraction-relaxation cycle in isolated cardiac myofibrils. J Physiol, 2005, 564 Pt 2:347-357.
  • 6Tsoutsman T, Chung J, Doolan A, et al. Molecular insights from a novel cardiac troponin I mouse model of familial hypertrophic cardiomyopathy. J Mol Cell Cardiol, 2006, 41:623-632.
  • 7Brito D, Madeira H. Malignant mutations in hypertrophic cardiomyopathy : fact or fancy? Rev Port Cardiol, 2005,24 : 1137- 1146.
  • 8Devereux RB. Left ventricular geometry, pathophysiology and prognosis[J]. J Am Coll Cardiol, 1995,25(4):885-887.
  • 9Molkentin JD, Lu JR, Antos CL, et al. A calcineurin dependent transcriptional pathway for cardiac hypertrophy[J]. Cell, 1998, 93(2):215-228.
  • 10Zou Y, Hiroi Y, Uozumi H, et al. Calcineurin plays a critical role in the development of pressure overload-induced cardiac hypertrophy[J]. Circulation, 2001,104(1): 97-101.

共引文献5

同被引文献10

引证文献3

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部